Lanicemine
- Generic Name
- Lanicemine
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C13H14N2
- CAS Number
- 153322-05-5
- Unique Ingredient Identifier
- 9TMU325RK3
- Background
Lanicemine has been used in trials studying the treatment and basic science of Depression, Major Depressive Disorder, and Treatment Resistant Major Depressive Disorder.
- Associated Conditions
- -
- Associated Therapies
- -
NMDA Receptor Modulation for Hyperarousal in PTSD
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2017-05-25
- Last Posted Date
- 2020-08-19
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 24
- Registration Number
- NCT03166501
- Locations
- 🇺🇸
Michael E. DeBakey VA Medical Center, Houston, Texas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath